Buradasınız

Anasayfa » Content

MODIFIED RELEASE OF DILTIAZEM HYDROCHLORIDE USING TRANSDERMAL DRUG DELIVERY SYSTEM

Journal Name:

  • The International Journal of Pharmaceutical Research and Bio-Science

Publication Year:

  • 2012

Key Words:

Author Name
Abstract (2. Language): 
The objective of present study was to investigate the suitable polymeric films for the development of diltiazem hydrochloride (diltiazem HCl) transdermal drug delivery systems. Hydroxypropyl methylcellulose (HPMC) and ethyl cellulose (EC) were used as hydrophilic and hydrophobic film formers, respectively. Effects of HPMC/EC ratios and plasticizers on mechanical properties of free films were studied. Matrix films were evaluated for their physicochemical characterization followed by in vitro evaluation. The Thickness and weight of patch increase with the increase in polymeric grade and content. Fourier transforms infrared spectroscopy results confirmed that there is no interaction between drug and polymer used. The in vitro drug release followed Higuchi kinetic as its coefficient of correlation values predominates over first order kinetics. Comparison of skin permeation rate between hairless rat and human cadaver skin was done by using diffusion cells. Out of the various formulations made, the selected formulations are better in their in vitro dissolution thus holds potential for transdermal delivery.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon arastirmax-modified-release-diltiazem-hydrochloride-using-transdermal-drug-delivery-system.pdf
  • 4
  • English

REFERENCES

References: 

1. Ansel HC, Allen LV and Popovich NG: Pharmaceutical Dosage Forms and Drug Delivery systems, seventh edition, Lippincott Williams & Wilkins, 2002: 263.
2. Chein YW: Transdermal drug delivery and delivery system. In Novel drug delivery system, Vol. 50, Marcel Dekker, Inc., New York 1992: 301-381.
3.
Kuma
r AJ, Pullakandam Nikhila, Lakshmana S and Gopal V. Transdermal drug delivery system: an overview. 2010; 3(2):49-54.
4.
William
s AC and Barry BW: Penetration enhancers. Advance Drug delivery Review,
2004; 56(5): 603-618.
Available Online At www.ijprbs.com
Research Article
Rupal Jani, IJPRBS, 2012; Volume 1(4): 360-370
5. Anna K and Nissim G: Microemulsion as transdermal drug delivery vehicles. Adv Colloid Interface Science, 2006; 123:126:
369-385.
6. Ming Man, Connie Chang, Theodore Broman and Gary W: New improved paddle method for determining the in vitro drug release profiles of transdermal delivery systems, Journal of Controlled Release.
1993; 52(3): 503-518.
7. Sankar V, Johnson DB, Sivanand V, Ravichandran V, Raghuraman S, Velrajan G, Palaniappan R, Rajasekar, S, Chandrasekaran K: Indian J Pharm Sci 2003;
65: 51 -515.
8. Kanikkannan N and Mandip S: Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. International Journal of Pharmaceutics,
2002; 284: 219-228.
9. Shakeel F, Baboota S, Ahuja A, Ali J, Aquil M and Shafiq S: Nanoemulsions as Vehicles for Transdermal Delivery of Aceclofenac. AAPS Pharmaceutical Science and
Technology, 2007; 8(4): E1-E9.
10. Bouchemal K, Briancon S, Perrier E and Fessi H: Nano-emulsion formulation using
ISSN: 2277-8713
IJPRBS
spontaneous emulsification: solvent, oil and surfactant optimization. International Journal of Pharmaceutics, 2004; 280: 241¬251.
11. Hadgraft J and Guy RH: Transdermal Drug Delivery, Second edition, Marcel
Dekker Inc, 2003; 35: 296.
12. Shiva Kumar HN, Vinay BL, Mulla JS, Jamakandi VG: Asian journal of pharmaceutics 2009; 59-65.

Thank you for copying data from http://www.arastirmax.com